- Intuitive Surgical ( NASDAQ: ISRG ) is scheduled to announce Q2 earnings results on Thursday, July 21st, after market close.
- The consensus EPS Estimate is $1.20 (-69.4% Y/Y) and the consensus Revenue Estimate is $1.56B (+6.8% Y/Y).
- Over the last 2 years, ISRG has beaten EPS estimates 100% of the time and has beaten revenue estimates 100% of the time.
- Over the last 3 months, EPS estimates have seen 2 upward revisions and 13 downward. Revenue estimates have seen 4 upward revisions and 10 downward.
- The company's reported Q1 beat last quarter, helped by recovery in demand for its da Vinci Surgical Systems.
- Last quarter, instruments and accessories revenue increased by 15% Y/Y to $810 million, primarily driven by about 19% growth in da Vinci procedure volume.
- The company in April had said COVID-19 has had, and will likely continue to have, an adverse impact on the Company’s procedure volumes. Shares of the company fell in April.
- ISRG raised its 2022 forecast for procedure growth to 12%-16% from 11%-15%, "the low end of the range assumes ongoing COVID and staffing pressure at hospitals and assume some continued choppiness with COVID throughout the year.
- Also read - Intuitive Surgical: Too Cheap For Robotic Surgery Leader
For further details see:
Intuitive Surgical to report Q2 result amid persistent COVID-19 headwinds